Clinical trial
A Trial of PEHRG214 in HIV-Infected Patients
NCT00385567 · Virionyx Corporation Limited, Industry · Terminated
Key facts
| NCT number | NCT00385567 |
|---|---|
| Title | A Trial of PEHRG214 in HIV-Infected Patients |
| Official title | A Phase 2 Randomized, Controlled Trial of PEHRG214 in HIV-Infected Patients |
| Lead sponsor | Virionyx Corporation Limited, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | PEHRG214 |
| Enrollment | 70 |
| Start date | Jan 1, 2007 |
| Primary completion | Sep 1, 2008 |
| Completion | Sep 1, 2008 |
| First posted | Oct 9, 2006 |
| Last update posted | Aug 26, 2010 |
| Countries | Puerto Rico, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: